MedPath

Comparison of HACOR and ROX score to predict failure of Non-invasive respiratory assist devices like NIV, HFNC

Not Applicable
Conditions
Health Condition 1: J960- Acute respiratory failure
Registration Number
CTRI/2022/11/047053
Lead Sponsor
Bharati Hospital and Research centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All Patients who are 18 years of age or older will be screened for AHRF, defined as tachypnea (respiratory rate > 25/ min), PaO2/FiO2 ratio <300, PaCO2 <45mmHg in absence of history of Chronic Respiratory Failure. All these patients will be receiving COT.

Patients with AHRF who fail COT will be identified by any of the following criteria-

1.Worsening tachypnea (RR > 35) ,

2.Oxygen saturation < 88% on FiO2 0.6 on Venturi mask

3.Signs of respiratory distress( decreased consciousness, tachycardia, paradoxical respiratory movements, use of accessory muscles)

Exclusion Criteria

1)Chronic respiratory failure,

2)Hemodynamic instability (systolic BP < 90 mm Hg or MAP < 65mm Hg despite use of vasopressors, ( Noradrenaline requirement > 0.1 mcg/kg/min or Dopamine requirement > 10mcg/kg/min )

3)A do-not-intubate order

4)Anticipated life expectancy less than 90 days

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Predicting failure of non invasive respiratory therapy (Both HFNC and NIV) in acute hypoxemic respiratory failure by calculating ROX index and HACOR scoreTimepoint: At 1 hour and 6 hours of initiation of NIV or HFNC
Secondary Outcome Measures
NameTimeMethod
To compare effectiveness of ROX index and HACOR score for predicting failure of non invasive respiratory therapy (NIV and HFNC) as defined by need of intubationTimepoint: 18 months;To study predictors of failure of non invasive respiratory therapyTimepoint: 18 months
© Copyright 2025. All Rights Reserved by MedPath